Olympus customers have reported difficulty sourcing the isopropyl alcohol needed to complete the reprocessing of flexible endoscopes.
Working with Best Sanitizers, which supplies cleaning chemistries for the Olympus endoscope reprocessor, OER-Pro, and other automated endoscope reprocessing products, Olympus will supply ALPET 70/30 isopropanol alcohol rinse to its customers during COVID-19.
Due to the constantly changing circumstances created by the COVID-19 pandemic, healthcare networks face a shortage of medical supplies, medical professionals and manufacturing and service personnel able to maintain medical devices.
In this context, Olympus is pursuing efforts to support healthcare institutions, including:
Olympus is working with healthcare organizations to preserve personal protective equipment for only the most essential healthcare worker, via use of its cloud-based, clinical collaboration platform MedPresence.
As the current COVID-19 crisis restricts in-person educational programs, Olympus University is offering a variety of Instructor-Led Continuing Education Presentations online.
Course topics include infection control and clinical topics across various specialties. In addition, online modules for continuing education credit are available for anytime learning.
Olympus' Life Science Group is enabling access to demo microscopes to allow pathologists the ability to review cases remotely.
Olympus Surgical Technologies America Redmond, CA and Brooklyn Park, MN are making use of 3D printers to create face shields that will be donated to healthcare institutions.
The ALPET offering is currently available through Olympus. Interested parties should contact their Olympus sales representative, or Olympus customer service at 1-800-848-9024.
Olympus offers optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project